Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-04-26
2009-08-25
Wollenberger, Louis (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07579450
ABSTRACT:
The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE.
REFERENCES:
patent: 3710795 (1973-01-01), Higuchi et al.
patent: 4683195 (1987-07-01), Mullis
patent: 4935363 (1990-06-01), Brown et al.
patent: 4959309 (1990-09-01), Dattagupta et al.
patent: 5070010 (1991-12-01), Hsu
patent: 5262564 (1993-11-01), Kun et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5338671 (1994-08-01), Scalice et al.
patent: 5459015 (1995-10-01), Janjic et al.
patent: 5475096 (1995-12-01), Gold et al.
patent: 5496938 (1996-03-01), Gold et al.
patent: 5503978 (1996-04-01), Schneider et al.
patent: 5567588 (1996-10-01), Gold et al.
patent: 5580737 (1996-12-01), Polisky et al.
patent: 5635615 (1997-06-01), Allen et al.
patent: 5637459 (1997-06-01), Burke et al.
patent: 5648214 (1997-07-01), Nieuwlandt et al.
patent: 5654151 (1997-08-01), Allen et al.
patent: 5660985 (1997-08-01), Pieken et al.
patent: 5668264 (1997-09-01), Janjic et al.
patent: 5672695 (1997-09-01), Eckstein et al.
patent: 5674685 (1997-10-01), Janjic et al.
patent: 5683867 (1997-11-01), Biesecker et al.
patent: 5686592 (1997-11-01), Wiegand et al.
patent: 5698687 (1997-12-01), Eckstein et al.
patent: 5705337 (1998-01-01), Gold et al.
patent: 5707796 (1998-01-01), Gold et al.
patent: 5723323 (1998-03-01), Kauffman et al.
patent: 5756291 (1998-05-01), Griffin et al.
patent: 5763173 (1998-06-01), Gold et al.
patent: 5763177 (1998-06-01), Gold et al.
patent: 5766853 (1998-06-01), Parma et al.
patent: 5789157 (1998-08-01), Jensen et al.
patent: 5817635 (1998-10-01), Eckstein et al.
patent: 5861254 (1999-01-01), Schneider et al.
patent: 5958691 (1999-09-01), Pieken et al.
patent: 6011020 (2000-01-01), Gold et al.
patent: 6013443 (2000-01-01), Heilig et al.
patent: 6020130 (2000-02-01), Gold et al.
patent: 6051698 (2000-04-01), Janjic et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 6207816 (2001-03-01), Gold et al.
patent: 6214806 (2001-04-01), Krieg et al.
patent: 6229002 (2001-05-01), Janjic et al.
patent: 6239116 (2001-05-01), Krieg et al.
patent: 6426434 (2002-07-01), Yoshida et al.
patent: 6429199 (2002-08-01), Krieg et al.
patent: 6498148 (2002-12-01), Raz et al.
patent: 6514948 (2003-02-01), Raz et al.
patent: 6653292 (2003-11-01), Krieg et al.
patent: 6737236 (2004-05-01), Pieken et al.
patent: 2003/0229021 (2003-12-01), Krah, III et al.
patent: 2004/0018530 (2004-01-01), Bowser et al.
patent: 2004/0180360 (2004-09-01), Wilson et al.
patent: 2006/0030535 (2006-02-01), Healy et al.
patent: 059235 (1996-01-01), None
patent: 2 183 661 (1987-06-01), None
patent: WO89/06694 (1989-07-01), None
patent: WO91/14436 (1991-10-01), None
patent: WO 91/19813 (1991-12-01), None
patent: WO92/05285 (1992-04-01), None
patent: WO 92/07065 (1992-04-01), None
patent: WO92/14842 (1992-09-01), None
patent: WO92/14843 (1992-09-01), None
patent: WO 96/10576 (1996-04-01), None
patent: WO 98/18480 (1998-05-01), None
patent: WO 03/102212 (2003-12-01), None
King et al. (2002) Biochemistry. 41:9696-9706.
Floege et al. (1999) Am. J. Pathology. 154:169-179.
International Search Report for PCT/US05/14361, mailed Jun. 20, 2006.
Mendonsa et al., “In Vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis”,Anal. Chem., 76: 5387-5392 (2004).
Wiegand et al., “High-affinity oligonucleotide ligands to human IgE inhibit binding to Fcε receptor I”,J. Immunol., 157: 221-230 (1996).
International Search Report for PCT/US05/43551, mailed Jun. 12, 2007.
Altschul et al., “Basic Local Alignment Search Tool”,J. Mol. Biol. 215:403-410 (1990).
Altschul et al., “Gapped BLAST and PSI-BLAST: A new generation of protein database search programs”,Nuc. Acids Res. 15:3389-3403 (1997).
Arthanari et al., “Fluoerescent dyes specific for quadruplex DNA”,Nuc. Acids Res. 26(16):3724-3728 (1996).
Cotten et al., “2′-O-methyl, 2′-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event”,Nuc. Acids Res. 19:2629-2635 (1991).
Froehler et al., “Deoxynucleoside H-Phosphonate Diester Intermediates in the Synthesis of Internucleotide Phosphate Analogues”,Tet. Lett. 27:5575-5578 (1986).
Froehler et al., “Synthesis of DNA via deoxynucleoside H-phosphonate intermediates”,Nuc. Acids Res. 14:5399-5407 (1986).
Green et al., “Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor”,Chem. Biol. 2(1):683-695 (1995).
Greenwald et al., “Highly water soluble taxol derivatives: 7-polyethylene Glycol Carbamates and Carbonates”,J. Org. Chem. 60:331-336 (1995).
Harris et al., “Effect of Pegylation on pharmaceuticals”,Nature2:214-221 (2003).
Hirose et al., “Rapid synthesis of Trideoxyribonucleotide blocks”,Tet. Lett. 28:2449-2452 (1978).
Hobbs et al., “Polynucleotides containing 2'-amino-2'deoxyibose and 2'-azido-2'-deoxyribose”,Biochemistry12:5138-5145 (1973).
Joyce et al., “Detection of G-Quartet structure in a DNA aptamer stationary phase using a fluorescent dye”,Applied Spectroscopy58(7): 831-835 (2004).
Krieg, “CpG motifs in bacterial DNA and their immune effects”,Annu. Rev. Immunol. 20:709-760 (2001).
Liu et al., “CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells”,Nat. Immunol., 4(7):687-93 (2003).
Macaya et al., “Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution”,Proc Natl. Acad. Sci. 90:3745-3749 (1993).
Marathias et al., “Structures of the potassium-saturated, 2 :1, and intermediate, 1 :1, forms of a quadruplex DNA”,Nuc. Acids Res. 28(9):1969-1977 (2000).
McGinnis et al., “BLAST : At the core of a powerful and diverse set of sequence analysis tools”,Nuc. Acids Res. 32 :WO20-W25 (2004).
Needleman & Wunsch, “A general method applicable to the search for similarities in the amino acid sequence of two proteins”,J. Mol. Biol. 48:443-453 (1970).
Padilla et al., “A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs”,Nuc. Acids Res. 30:138 (2002).
Pearson & Lipman, “Improved tools for biological sequence comparison”,Proc. Natl. Acad. Sci. 85:2444-2448 (1988).
Pietersz et al., “A 16-mer peptide (RQIKIWFQNRRMKWKK) from Antennapedia preferentially targets the Class I pathway”,Vaccine19(11-12):1397-1405 (2003).
Rothbard et al., “Arginine-Rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake”,J. Med. Chem. 45(17):3612-3618 (2002).
Rothbard et al., “Conjugation of Arginine Oligomers to Cyclosporin A facilitates topical delivery and inhibition of inflammation”,Nat. Med. 6(11):1253-1257 (2000).
Smith & Waterman, “Comparison of bio-sequences”,Adv. Appl. Math. 2:482-489 (1981).
Sood et al., “A rapid and convenient synthesis of poly-thymidylic acid by the modified triester approach”,Nuc. Acids Res. 4:2757-65 (1977).
Sproat et al., “New Synthetic Routes to synthons suitable for 2'-O-allyloligoribonucleotide assembly”,Nuc. Acids Res. 19:733-738 (1991).
Tucker et al., “Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys”,J. Chromatography Biomed. Sci. Appl. 732(1):203-212 (Sep. 1999).
Vives et al., “A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus”,J. Biol. Chem. 272(25): 16010-7 (1997).
Andrak
Burmeister Paula
Cload Sharon
Diener John L.
Keefe Anthony Dominic
Keene Sara Chesworth
Archemix Corp.
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Wollenberger Louis
LandOfFree
Nucleic acid ligands specific to immunoglobulin E and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid ligands specific to immunoglobulin E and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid ligands specific to immunoglobulin E and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088213